The Ellis Martin Report
In this episode, Michael Rapsch, VP of Corporate Communications for SILVERCREST Metals -SIL.V discusses recent news with regard to the Las Chispas Project in Sonora State Mexico. Listen Now
The Ellis Martin Report
Join Ellis for a conversation with Marissa Arreola. Ms. Arreola is the President of Concertis, a wholly-owned subsidiary of Nobilis Health, trading in the US as HLTH. Listen Now
The Ellis Martin Report
In this episode, Ellis Martin chats with longtime sponsor Nobilis Health's (HLTH)VP of Corporate Development Kolin Ozonian about the company's peer leading marketing and acquisition strategy for success. Listen Now
The Ellis Martin Report
Ellis speaks with Dr. Brad Thompson of Oncolytics Biotech about recent progress related to colorectal and lung cancer studies. Listen Now
The Ellis Martin Report
In this episode you'll find three exclusive interviews: Stakeholder Gold's Listen Now
The Ellis Martin Report
Join Ellis Martin for a conversation with Chris Berlet, the President of Stakeholder Gold Corporation, trading in the US as SKHRF and on the TSX Venture Exchange as SRC. Listen Now
The Ellis Martin Report
In this episode, Ellis Martin speaks with Eric Fier, President of SilverCrest Metals Listen Now
The Ellis Martin Report
n this episode, Ellis speaks with Michael Ballanger of Stakeholder Gold(SKRHF)(SRC.V) about their Ballarat Gold Property in the Canadian Yukon and an astromical silver bull boom! Listen Now
The Ellis Martin Report
In this episode, Ellis speaks with Michael Ballanger of Stakeholder Resource Listen Now
The Ellis Martin Report
Today on the program Ellis will speak with renowned Yukon Gold prospector Shawn Ryan about his path from a penniless mushroom farmer to a wealthy gold prospector and his position as a member of the advisory board for sponsor Stakeholder Gold trading on the TSX Venture as SRC and in the US as SKHRF. Listen Now
The Ellis Martin Report
This episode Ellis speaks with gold and silver analyst Michael Ballanger, the advisory committee chairman of Stakeholder Gold (SRC on the TSX Venture and SKHRF in the US) about market trends and their Ballarat Gold property in the Yukon. Listen Now
The Ellis Martin Report
This episode Ellis speaks with gold and silver analyst Michael Ballanger, the advisory committee chairman of Stakeholder Gold Listen Now
The Ellis Martin Report
Ellis Martin opines about the coming gold rush as well as his thoughts on investing in gold and silver stocks now. Listen Now
The Ellis Martin Report
Ross Orr of Bactech Environmental trading on the CSE as BAC and in the US as BCCEF chat's about his company’s technology that can combat toxic mining tailings turning them into profit potentially for the surrounding communities as well as investors. Listen Now
The Ellis Martin Report
Ross Orr of Bactech Environmental trading on the CSE as BAC and in the US as BCCEF chat's about his company’s technology that can combat toxic mining tailings turning them into profit potentially for the surrounding communities as well as investors. Listen Now
The Ellis Martin Report
In this episode of The Ellis Martin Report we chat with precious metals analysts and newsletter writers Dudley Baker and David Morgan about the recent interest in gold and silver. Is this the final bull run? Listen Now
The Ellis Martin Report
Ellis Martin visits friends and sponsors at the Vancouver Resource Investment Conference. Interviews include Mickey Fulp of www.mercenarygeologist.com Listen Now
The Ellis Martin Report
Ellis Martin speaks with Eric Fier of SilverCrest Metals Listen Now
The Ellis Martin Report
On this week’s edition of The Ellis Martin Report, you’ll hear several interviews from Ellis’ short trip up to San Francisco for the Cambridge House Silver Summit and Resource Investment Conference. Listen Now
The Ellis Martin Report
In this first show of the year for The Ellis Martin Report, Ellis rants about good health advising you in the nicest way possible to get on a treadmill with a good TV show or movie. Listen Now
The Ellis Martin Report
Today on the program you’ll hear an interview with Ellis and Paul Gill, CEO of Lomiko Metals, trading as LMR on the TSX Venture Exchange and LMRMF on the OTC. Listen Now
The Ellis Martin Report
Today on the program you’ll hear a new interview with Dr. Brad Thompson of Oncolytics Biotech trading as ONC on the TSX and ONCY on the OTCQX. Listen Now
The Ellis Martin Report
Today on the program we’ll visit with Dr. William H. Andrews of Sierra Sciences with an unsponsored, not paid for segment discussing his research and successes in curing the disease of aging, leading to potential mortality. Listen Now
The Ellis Martin Report
On this week’s edition of The Ellis Martin Report, you’ll hear several interviews from Ellis’ short trip up to San Francisco for the Cambridge House Silver Summit and Resource Investment Conference. Listen Now
The Ellis Martin Report
Ellis Martin speaks with Dr. Brad Thompson of Oncolytics Biotech (ONCY) about both preventing cancer and treating it through Reolysin therapy. Listen Now
The Ellis Martin Report
In this episode, Dr. Brad Thompson returns to discuss success in the field of oncology, fighting cancer tumors with proprietary Reolysin technology with 1100 patients treated to date via his company Oncolytics Biotech Listen Now
The Ellis Martin Report
Listen Now
The Ellis Martin Report
In this episode join Ellis for a look at Success Holding trading as SHGT on the OTCBB and their founder Steve Chen Listen Now
The Ellis Martin Report
In this episode join Ellis for a look at Success Holding trading as SHGT on the OTCBB and their founder Steve Chen Listen Now
The Ellis Martin Report
Dr. Brad Thompson, President of Oncolytics Biotech Inc. (NASDAQ:ONCY/TSX:ONC) Oncolytics Biotech is a biotechnology company focused Listen Now
The Ellis Martin Report
Dr. Brad Thompson, President of Oncolytics Biotech Inc. (NASDAQ:ONCY/TSX:ONC) Listen Now
The Ellis Martin Report
Dr. Brad Thompson, President of Oncolytics Biotech Inc. (NASDAQ:ONCY/TSX:ONC) Oncolytics Biotech is a biotechnology company focused Listen Now
The Ellis Martin Report
Dr. Brad Thompson, President of Oncolytics Biotech Inc. (NASDAQ:ONCY/TSX:ONC) Oncolytics Biotech is a biotechnology Listen Now
The Ellis Martin Report
Today on the program Ellis speaks with Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ Listen Now
The Ellis Martin Report
Today on the program Ellis speaks with Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ and ONC on the TSX. Listen Now
The Ellis Martin Report
On this program Ellis speaks with a new sponsor Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ and ONC on the TSX. Listen Now
The Ellis Martin Report
Today on the program Ellis speaks with a new sponsor Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ Listen Now
© Copyright 1997-2024 VoiceAmerica Internet Talk Radio.The World Leader in Internet Talk Radio. All Rights Reserved.
